ALNYLAM PHARMACEUTICALS, INC. PP&E Net 2009-2025 | ALNY
Beta
What is ALNYLAM PHARMACEUTICALS, INC.'s current pp&e net?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual pp&e net for 2025 was $513.1M, a 2.06% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. pp&e net for the quarter ending December 31, 2025 was $513.1M.
What was ALNYLAM PHARMACEUTICALS, INC.'s pp&e net in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual pp&e net for 2024 was $502.8M, a 4.42% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s pp&e net in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual pp&e net for 2023 was $526.1M, a 0.49% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year pp&e net CAGR?
ALNYLAM PHARMACEUTICALS, INC. pp&e net grew at a compound annual growth rate (CAGR) of 1.99% from FY2020 to FY2025, going from $465.0M to $513.1M over 5 years.
PP&E Net History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+2.0%
FY2020
$465.0M
→
FY2025
$513.1M
0910111213141516171819202122232425
5 years selected
PP&E Net History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $513.1M | +2.1% | 10-K |
| FY2024 | $502.8M | -4.4% | 10-K |
| FY2023 | $526.1M | +0.5% | 10-K |
| FY2022 | $523.5M | +4.3% | 10-K |
| FY2021 | $502.0M | +7.9% | 10-K |
| FY2020 | $465.0M | +9.4% | 10-K |
| FY2019 | $425.2M | +32.6% | 10-K |
| FY2018 | $320.7M | +76.3% | 10-K |
| FY2017 | $181.9M | +58.8% | 10-K |
| FY2016 | $114.6M | +312.0% | 10-K |
| FY2015 | $27.8M | +27.9% | 10-K |
| FY2014 | $21.7M | +32.2% | 10-K |
| FY2013 | $16.4M | -16.9% | 10-K |
| FY2012 | $19.8M | +35.2% | 10-K |
| FY2011 | $14.6M | -19.9% | 10-K |
| FY2010 | $18.3M | -0.2% | 10-K |
| FY2009 | $18.3M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →